• Citer

Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity

par Eggermont, Alexander A.M.M.;Testori, Alessandro;Suciu, Stefan ;Rutkowski, Piotr;Kruit, Wim H;Punt, Cornelis;Dummer, Reinhard;Sales, François ;Keilholz, Ulrich;de Schaetzen, Gaetan
Référence European journal of cancer, 55, page (111-121)
Publication Publié, 2016-03

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity
Auteur:	Eggermont, Alexander A.M.M.; Testori, Alessandro; Suciu, Stefan; Rutkowski, Piotr; Kruit, Wim H; Punt, Cornelis; Dummer, Reinhard; Sales, François; Keilholz, Ulrich; de Schaetzen, Gaetan
Informations sur la publication:	European journal of cancer, 55, page (111-121)
Statut de publication:	Publié, 2016-03
Sujet CREF:	Cancérologie
Mots-clés:	Adjuvant
	Interferon
	Melanoma
	Predictive factors
	Randomised trial
	Ulceration
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2015.11.014
	info:pii/S0959804915010448
	info:scp/84954458766